Continue Reading on TOI App
Open
OPEN APP

DCGI nod to Covaxin for use in children above 12 years with certain conditions

NEW DELHI: The Drugs Controller General of India (

DCGI

) has granted emergency use authorisation to Bharat Biotech's Covaxin for children above 12 years with certain conditions, sources said on Saturday.

The

Subject Expert Committee

on Covid-19 of the CDSCO on October 12 after deliberating Bharat Biotech's

EUA

application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.

"The recommendations of the

SEC

were evaluated by another experts committee after which DCGI had sought additional data from the firm," a source said.

The DCGI gave its approval Friday, the source said.
Continue Reading
Follow Us On Social Media
end of article
More Trending Stories
Visual Stories
More Visual Stories
UP NEXT
Do Not Sell Or Share My Personal Information